Douglas G. Forsyth

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kelly D. Deck, as attorney-in-fact for Douglas G. Forsyth
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Douglas G. Forsyth

Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
224,564
Estimated value
$3,159,615
Report date
23 Aug 2024
Price
$14.07
Ownership
By the Forsyth Family Trust Dated July 20, 2001
Form 4 holding Director

Inhibrx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
30 May 2024
Price
$30.00
Ownership
By the Forsyth Family Trust Dated July 20, 2001
Form 4 holding Director

Inhibrx, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
$0
Report date
30 May 2024
Price
$34.12
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Douglas G. Forsyth

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .